PolyPid Ltd has a consensus price target of $15.17 based on the ratings of 6 analysts. The high is $25 issued by BMO Capital on August 11, 2022. The low is $4 issued by Raymond James on September 6, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on June 18, 2024, May 9, 2024, and May 1, 2024, respectively. With an average price target of $14 between HC Wainwright & Co., there's an implied 250.00% upside for PolyPid Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/18/2024 | Buy Now | 250% | HC Wainwright & Co. | Raghuram Selvaraju | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 250% | HC Wainwright & Co. | Raghuram Selvaraju | → $14 | Reiterates | Buy → Buy | Get Alert |
05/01/2024 | Buy Now | 250% | HC Wainwright & Co. | Raghuram Selvaraju | → $14 | Reiterates | Buy → Buy | Get Alert |
10/23/2023 | Buy Now | 150% | Barclays | Balaji Prasad | $2.5 → $10 | Maintains | Equal-Weight | Get Alert |
10/12/2023 | Buy Now | 300% | HC Wainwright & Co. | Raghuram Selvaraju | → $16 | Initiates | → Buy | Get Alert |
09/07/2022 | Buy Now | -37.5% | Barclays | Balaji Prasad | $660 → $75 | Downgrade | Overweight → Equal-Weight | Get Alert |
09/06/2022 | Buy Now | — | Raymond James | Elliot Wilbur | $450 → $120 | Downgrade | Strong Buy → Outperform | Get Alert |
08/11/2022 | Buy Now | 525% | BMO Capital | Gary Nachman | $810 → $750 | Maintains | Outperform | Get Alert |
02/11/2022 | Buy Now | 325% | Raymond James | Elliot Wilbur | $690 → $510 | Maintains | Strong Buy | Get Alert |
09/14/2021 | Buy Now | 250% | JMP Securities | — | — | Initiates | → Market Outperform | Get Alert |
07/30/2021 | Buy Now | 500% | Cantor Fitzgerald | Brandon Folkes | — | Initiates | → Overweight | Get Alert |
The latest price target for PolyPid (NASDAQ:PYPD) was reported by HC Wainwright & Co. on June 18, 2024. The analyst firm set a price target for $14.00 expecting PYPD to rise to within 12 months (a possible 250.00% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for PolyPid (NASDAQ:PYPD) was provided by HC Wainwright & Co., and PolyPid reiterated their buy rating.
There is no last upgrade for PolyPid
The last downgrade for PolyPid Ltd happened on September 7, 2022 when Barclays changed their price target from $22 to $2.5 for PolyPid Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PolyPid, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PolyPid was filed on June 18, 2024 so you should expect the next rating to be made available sometime around June 18, 2025.
While ratings are subjective and will change, the latest PolyPid (PYPD) rating was a reiterated with a price target of $14.00 to $14.00. The current price PolyPid (PYPD) is trading at is $4.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.